Medicine and Dentistry
Artery
6%
Atherosclerosis
8%
Biological Marker
20%
Biopsy
10%
Blood Flow
6%
Blood Pressure
7%
Brain Blood Flow
8%
Brain Tumor
6%
Breast Cancer
7%
Breathing
6%
Cardiovascular Disease
8%
Cardiovascular Risk
5%
Cardiovascular System
13%
Clinical Trial
9%
Cohort Analysis
6%
Computer Assisted Tomography
20%
Copper 64
17%
Coronary Artery Disease
8%
Coronary Circulation
6%
COVID-19
7%
Diabetes Mellitus
6%
Diagnosis
35%
Diagnostic Accuracy
6%
Disease
27%
Drug Therapy
5%
Fluorine-18
29%
Fluorodeoxyglucose
7%
Fluorodeoxyglucose F 18
41%
Gallium 68
11%
Ganglioglioma
10%
Gene Expression
7%
Glioblastoma
10%
Glomerular Filtration Rate
7%
Glucose Uptake
8%
Hazard Ratio
5%
Head and Neck Cancer
9%
Head and Neck Squamous Cell Carcinoma
7%
Headache
6%
Heart Failure
7%
Heart Left Ventricle Ejection Fraction
7%
Heart Muscle Perfusion
11%
Hodgkin's Lymphoma
10%
Human Immunodeficiency Virus
7%
Hypoxia
5%
Iodine 123
7%
Kidney Function
6%
Low Drug Dose
8%
Lung Cancer
13%
Magnetic Resonance Imaging
52%
Magnetic Resonance Imaging
7%
Malignant Neoplasm
21%
Maturity Onset Diabetes of the Young
10%
Meningioma
6%
Metastatic Carcinoma
10%
Migraine
8%
Molecular Imaging
10%
Myocardial Perfusion Imaging
8%
Neoplasm
55%
Neuro-Oncology
6%
Neuroendocrine Tumor
28%
Nodular Melanoma
6%
Non Small Cell Lung Cancer
5%
Nuclear Magnetic Resonance
5%
Nuclear Medicine
13%
Overall Survival
9%
Patient with Type 2 Diabetes
5%
Pediatrics
11%
Placebo
13%
Positron Emission Tomography
100%
Positron Emission Tomography
74%
Positron Emission Tomography - Magnetic Resonance Imaging
21%
Positron Emission Tomography-Computed Tomography
71%
Prevalence
7%
Primary Tumor
8%
Progression Free Survival
6%
Prospective Study
7%
Prostate Cancer
7%
Radiation Therapy
21%
Radioactive Tracer
28%
Radioisotope
6%
Radionuclide Therapy
6%
Randomized Controlled Trial
9%
Recurrent Disease
9%
Rubidium 82
14%
Scintigraphy
14%
Sentinel Node
8%
Single Photon Emission Computed Tomography-Computed Tomography
6%
Single-Photon Emission Computed Tomography
18%
Skeletal Muscle
7%
Somatostatin Receptor
9%
Standardized Uptake Value
7%
Surgery
6%
Symptom
9%
Systematic Review
6%
Tetraxetan
9%
Treatment Response
7%
Tumor Xenograft
7%
Urokinase Receptor
18%
Volunteer
11%
Xenograft
6%
Keyphrases
18F-FDG PET-CT
15%
18F-fluorodeoxyglucose (18F-FDG)
25%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
21%
211At
8%
5-HT2A Receptor
10%
64Cu-DOTATATE
7%
AE105
9%
Alzheimer's Disease
10%
Antipsychotics
14%
Attenuation Correction
11%
Blood Flow
8%
Blood Pressure
7%
Body Mass Index
7%
Brain Imaging
7%
Cancer Patients
11%
Cardiovascular Risk
7%
Cerebral Blood Flow
16%
Chemotherapy
10%
Computed Tomography
18%
Confidence Interval
13%
Copenhagen
11%
COVID-19
9%
Denmark
12%
Diagnostic Accuracy
8%
FDG PET-CT
10%
FDG Uptake
10%
Fluorodeoxyglucose
7%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
14%
Functional Magnetic Resonance Imaging
13%
Gallium-68
14%
Gene Expression
8%
Glioblastoma
9%
Glucagon-like
12%
Glucose Uptake
7%
Hazard Ratio
7%
Head-and-neck Cancer
10%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
8%
Headache
8%
Healthy Controls
16%
Healthy Individuals
10%
Healthy Volunteers
16%
Hodgkin Lymphoma
8%
Human Brain
7%
Hypertension
9%
Hypoxia
8%
In Vivo Evaluation
9%
Left Ventricular Ejection Fraction
9%
Liposomes
10%
Lung
7%
Lung Cancer
9%
Magnetic Resonance Imaging
28%
Migraine
8%
Migraine without Aura (MWoA)
9%
Molecular Imaging
8%
Multiple Sclerosis
9%
Myocardial Flow Reserve
10%
Myocardial Infarction
8%
Myocardial Perfusion
9%
Nave
11%
Neuroendocrine Neoplasms
11%
Neuroendocrine Tumor
14%
NODAGA
8%
Nuclear Imaging
7%
Nuclear Medicine
11%
Overall Survival
9%
Perfusion
15%
PET Imaging
19%
PET Scan
10%
PET Tracer
10%
PET-MRI
34%
Placebo
13%
Positron Emission Tomography
95%
Positron Emission Tomography Study
7%
Positron Emission Tomography Tracers
8%
Positron Emission Tomography-computed Tomography (PET-CT)
55%
Positron Emission tomography-CT
10%
Prognostic Value
11%
Radiation Therapy
9%
Radioligand
11%
Radiotherapy
12%
Randomized Controlled Trial
10%
Receptor Agonist
7%
Receptor Binding
13%
Retargeting
11%
Rubidium-82
8%
Schizophrenia
7%
Schizophrenic Patients
9%
Serotonin 2A Receptor (5-HT2AR)
13%
Serotonin Transporter
7%
Single-photon Emission Computed Tomography (SPECT)
21%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
22%
Standardized Uptake Value
9%
SUVmax
11%
Technetium-99m
7%
Tetrazine
10%
Tumor
25%
Type 1 Diabetes Mellitus (T1DM)
9%
Type 2 Diabetes Mellitus (T2DM)
13%
Type 2 Diabetic Patients
12%
Type I Diabetes
8%